DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
8.11
-0.34 (-4.02%)
At close: Mar 27, 2026, 4:00 PM EDT
8.42
+0.31 (3.82%)
After-hours: Mar 27, 2026, 4:04 PM EDT
DarioHealth Revenue
In the year 2025, DarioHealth had annual revenue of $22.36M, down -17.31%. DarioHealth had revenue of $5.23M in the quarter ending December 31, 2025, a decrease of -31.21%.
Revenue (ttm)
$22.36M
Revenue Growth
-17.31%
P/S Ratio
2.65
Revenue / Employee
$135,509
Employees
165
Market Cap
59.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.36M | -4.68M | -17.31% |
| Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
| Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
| Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
| Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
| Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
| Dec 31, 2019 | 7.56M | 165.00K | 2.23% |
| Dec 31, 2018 | 7.39M | 2.22M | 43.02% |
| Dec 31, 2017 | 5.17M | 2.37M | 84.45% |
| Dec 31, 2016 | 2.80M | 1.98M | 240.58% |
| Dec 31, 2015 | 823.00K | 772.00K | 1,513.73% |
| Dec 31, 2014 | 51.00K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TruBridge | 347.27M |
| Health Catalyst | 311.14M |
| American Well | 249.33M |
| Definitive Healthcare | 241.52M |
| LifeMD | 194.06M |
| CareCloud | 120.50M |
| OptimizeRx | 109.43M |
| Forian | 28.11M |
DRIO News
- 8 days ago - DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - PRNewsWire
- 16 days ago - DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 - PRNewsWire
- 17 days ago - Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health - PRNewsWire
- 24 days ago - Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management - PRNewsWire
- 2 months ago - Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms - PRNewsWire
- 3 months ago - Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members - PRNewsWire
- 4 months ago - Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio - PRNewsWire